2Inman RD, Whittum-Hudson JA, Schumacher HR, et al. Chlamydia and associated arthritis. Curr Opin Rheumatol, 2000,12: 254-262.
3Gerard HC, Branigan PJ, Schumacher HR Jr, et al. Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol, 1998, 25: 734-742.
4Beatty WL, Morrison RP, Byrne GI. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev, 1994, 58: 686-699.
5Koehler L, Nettelnbreker E, Hudson AP, et al. Ultrastructural and molecular analyses of the persistence of Chlamydia trachomatis (serovar K) in human monocytes. Microb Pathog, 1997, 22: 133-142.
6Jones ML, Gaston JS, Pearce JH. Induction of abnormal Chlamydia trachomatis by exposure to interferon-gamma or amino acid deprivation and comparative antigenic analysis. Microb Pathog, 2001, 30: 299-309.
7Belland R J, Nelson DE, Virok D, et al. Transcriptome analysis of chlamydial growth during IFN-gamma-mediated persistence and reactivation. Proc Natl Acad Sci U S A,2003, 100: 15971-15976.
8Byrne GI, Ouellette SP, Wang Z, et al.Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2cells. Infect Immun, 2001, 69: 5423-5429.
9Popov I, Dela Cruz CS, Barber BH, et al.Breakdown of CTL tolerance to self HLAB*2705 induced by exposure to Chlamydia trachomatis. J Immunol, 2002, 169: 4033-4038.
10Ramos M, Alvarez I, Sesma L, et al.Molecular mimicry of an HLA-B27-derived ligand of arthritis-linked subtypes with chlamydial proteins. J Biol Chem, 2002,277: 37573-37581.
1Vodstrcil LA,Mclver R,Huston WM,et al. The epidemiolo-gy of chlamydia trachomatis organism load during geni-tal infection;A systematic review[ J]. J Infect Dis,2015,211(10):1628 -1645.
2Detels R,Green AM, Klausner JD, et al. The incidenceand correlates of symptomatic and asymptomaticChlamydia trachomatis and Neisseria gonorrhoeae in-fections in selected populations in five countries[J]. SexTransm Dis,2011,38(6) :503 -509.
3Trojian TH,Lishnak TS’Heiman D. Epididymitis and orchi-tis: an overview [J]. Am Fam Physician, 2009,79(7) :583-587.
4Redgrave KA,McLaughlin EA. The role of the immune re-sponse in chlamydia trachomatis infection of the malegenital 甘ad:A Double-Edged Sword[J]. Front Immunol.2014,5:534.
5Ito S,Hanaoka N’Shimuta K,et al. Male non-gonococcalurethritis ; From microbiological etiologies to demographicand clinical features); J]. Int J Urol,2016,23(4) :325 -331.
6Takahashi SJakeyama K,Kunishima Y,et al. Analysis ofclinical manifestations of male patients with urethritis[J]. J Infect Chemother,2006,12(5) :283 -286.
7Cunningham KA, Beagley KW. Male genital tractchlamydial infection : implications for pathology and infer-tility [J]. Biol Reprod,2008,79(2) :180-189.
8Furuya R,Takahashi S,Furuya S,et al. Is seminal vesiculi-tis a discrete disease entity? Clinical and microbiologicalstudy of seminal vesiculitis in patients with acute epididy-mitis [J]. J Urol,2004,171(4):1550 -1553.
9Furuya R,Takahashi S, Furuya S,ef al. Is urethritis ac-companied by seminal vesiculitis? [J].lnt J Urol,2009,6(7) :628 -631.
10Mackern-Oberti JP, Motrich RD, Breser ML, et al.Chlamydia trachomatis infection of the male genitaltract:an update[J]. J Reprod Immunol,2013,100( 1):37 -53.
